Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV− and HPV+ Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV− and HPV+ Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy

Published:2019-07-02 Issue:21 Volume:25 Page:6463-6474
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Xiao Roy,An Yi,Ye Wenda,Derakhshan Adeeb,Cheng Hui,Yang Xinping,Allen Clint,Chen Zhong,Schmitt Nicole C.,Van Waes Carter

Funder

NIDCD

Doris Duke Charitable Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck;Cancer Treatment Reviews;2024-09

2. Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres;BMC Cancer;2024-06-07

3. Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma;Cancer Research Communications;2024-06-06

4. Development and Validation of a Pathomics Model Using Machine Learning to Predict <i>CXCL8</i> Expression and Prognosis in Head and Neck Cancer;Clinical and Experimental Otorhinolaryngology;2024-02-29

5. Clinically used drug arsenic trioxide targets XIAP and overcomes apoptosis resistance in an organoid-based preclinical cancer model;Chemical Science;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP